Breegi Scientific

Breegi Scientific Inc. (BSI) is an international medical technology company headquartered in Boston, Massachusetts, and founded in 2014. The company is dedicated to addressing the global infant mortality crisis through the development of the Neonatal Intensive Care Incubator (NICI™), a portable, disposable, and low-cost neonatal incubator platform. NICI is designed to provide critical neonatal care—including heat, humidity, oxygen, phototherapy, and HEPA filtration—in a compact, single-use housing paired with a reusable electronic control module. According to the company, NICI costs less than 1% of the cost, size, and weight of traditional hospital incubators, making it suitable for both high-resource and low-resource settings. Breegi Scientific has received international grants and awards to support its work, and its second platform, the Negative Pressure SteriDome (NPS), received Emergency Use Authorization from the U.S. FDA in May 2021 for protecting frontline workers during the COVID-19 pandemic. The company's long-term vision is a world where no infant dies due to lack of access to neonatal incubators and where biocontainment solutions are safe, effective, and accessible.

Breegi Scientific Inc. (BSI) was founded in 2014 in Boston, Massachusetts, as an international medical technology company. The company's primary mission is to reduce global neonatal mortality and morbidity by developing accessible, low-cost neonatal care solutions. Its flagship product, the Neonatal Intensive Care Incubator (NICI™), was created to fundamentally change the century-old paradigm of neonatal incubators. NICI consists of a single-use, disposable infant housing and a reusable electronic control module, providing heat, humidity, oxygen, phototherapy, and HEPA filtration in a portable platform. The company states that NICI is less than 1% of the cost, size, and weight of standard hospital incubators. Breegi Scientific has received several prestigious international grants and awards to support the development of NICI. In response to the COVID-19 pandemic, the company leveraged its patented biocontainment platform to develop the Negative Pressure SteriDome (NPS), which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration in May 2021. The company continues to work with a global team of experts across six continents to scale its clinical platform for healthcare systems worldwide.

• Breegi Scientific Inc. founded in Boston, Massachusetts.

• Negative Pressure SteriDome (NPS) receives FDA Emergency Use Authorization.

• First infant treated with NICI neonatal incubator.

Affordable, portable, disposable neonatal care and biocontainment solutions for global health.

• NICI™ (Neonatal Intensive Care Incubator)

  A portable, disposable neonatal incubator platform consisting of a single-use infant housing and a reusable control module. Provides heat, humidity, oxygen, phototherapy, and HEPA filtration.

• Negative Pressure SteriDome (NPS)

  A biocontainment solution developed from the company's patented platform, receiving FDA EUA in May 2021.

1. 1Disposable Biocontainment | Incubators | nici | boston | SteriDome | Breegi USAbreegiscientific.com
2. 2Aerosol hood | nici | Healthcare incubator | Isolation Chamber Bobreegiscientific.com
3. 3About Us | BreegiScientific | Healthcare incubator | Isolation Chamber Bostonbreegiscientific.com
4. 4Breegi Scientificwikidata.org